There is a wide range of drugs with the potential to cause ischaemic stroke. Whilst the absolute risk of stroke with commonly used drugs is low, a patient's background risk of stroke can increase their chance of stroke in combination with a particular drug. Careful decision-making is required when initiating and continuing treatment to ensure the risk-benefit profile of a drug is weighed appropriately on an individual patient basis.
Department of Clinical Pharmacology, St George's, University of London, London, UK.
Correspondence to Daniel R. Burrage, Honorary Senior Lecturer in Clinical Pharmacology, Mailpoint J1A, St George's, University of London, Cranmer Terrace, London, SW17 0RE, UK. E-mail: firstname.lastname@example.org
Editor: Kim Peder Dalhoff, MD, DMSc, FEAPCCT, Professor of Clinical Pharmacology, Department of Clinical Pharmacology, Bispebjerg and Frederiksberg University Hospital, 2400 Copenhagen, Denmark. Associate Editor: Jon Trærup Andersen, MD, PhD. Editorial Board: Australia: Dr M Kennedy, Professor G M Shenfield; Denmark: Professor M Andersen; England: Dr J K Aronson, Dr A Hitchings; India: Professor N Gogtay; Ireland: Professor D Williams; Netherlands: Professor C J van Boxtel, B H Ch Stricker; Sweden: Dr S Hagg; Wales: Professor P A Routledge.